Literature DB >> 6175341

High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors.

M Schapira, C F Scott, A James, L D Silver, F Kueppers, H L James, R W Colman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175341     DOI: 10.1021/bi00532a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  11 in total

1.  Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.

Authors:  P N Walsh; D Sinha; F Kueppers; F S Seaman; K B Blankstein
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

Review 2.  Surface-mediated defense reactions. The plasma contact activation system.

Authors:  R W Colman
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

3.  Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.

Authors:  A de Agostini; H R Lijnen; R A Pixley; R W Colman; M Schapira
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

4.  Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.

Authors:  C F Scott; L D Silver; M Schapira; R W Colman
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

5.  Binding of high-molecular-mass kininogen to the Apple 1 domain of factor XI is mediated in part by Val64 and Ile77.

Authors:  F S Seaman; F A Baglia; J A Gurr; B A Jameson; P N Walsh
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

6.  Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.

Authors:  M Schapira; M A Ramus; S Jallat; D Carvallo; M Courtney
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

7.  Inactivation of kallikrein in human plasma.

Authors:  F van der Graaf; J A Koedam; B N Bouma
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

8.  High-molecular weight kininogen. A secreted platelet protein.

Authors:  A H Schmaier; A Zuckerberg; C Silverman; J Kuchibhotla; G P Tuszynski; R W Colman
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

9.  Guinea pig macroalbumin. A major inhibitor of activated Hageman factor in plasma with an alpha 2-macroglobulin-like nature.

Authors:  T Ishimatsu; T Yamamoto; K Kozono; T Kambara
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

10.  Failure of guinea pig plasma kallikrein to cause neutrophil migration.

Authors:  T Imamura; T Yamamoto; K Kozono; T Kambara
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.